Biofrontera Inc. reported a 29.8% increase in net product revenue to $9.1 million for Q3 2026, driven by FDA approval of Ameluz for superficial basal cell carcinoma and a favorable ruling on its RhodoLED XL-C lamp. Gross margin improved to 74.4%, and adjusted EBITDA loss narrowed compared to the prior year. The company plans to commercialize Ameluz for new indications in late 2026 and early 2027, aiming to expand its dermatology market presence.
Biofrontera Inc.'s strong Q3 2026 financial results provide context for readers. For those following the health sector, here is Pluang's market snapshot as of Nov 13, 2026 19:41 WIB: Out of 150 health-sector US stocks, 99 rose and 43 fell today. Baxter International Inc. (BAX) gained 3.30% to USD 26.59 with a typical hold time of 71 days, contrasting with Citius Pharmaceuticals Inc. (CTXR) which dropped 4.21% to USD 0.51 and saw 84% sell orders, and Tango Therapeutics Inc. (TNGX) down 3.42% at USD 24.00 with a much shorter hold time of 4 days.
Michelin has announced the total number of its voting rights and shares as of October 31, 2026. The company has 691,516,292 shares and 960,075,649 voting rights, considering 20,287,710 treasury shares. This disclosure complies with French regulations...
Michelin has disclosed the total number of voting rights and shares composing its capital as of October 31, 2026. The company reported 691,516,292 shares, with theoretical voting rights totaling 980,363,359 and exercisable voting rights at 960,075,64...
KeyBanc lowered its price target for YETI Holdings to $49, suggesting a 27.94% upside from the current $38.30 stock price. This follows YETI's reduction of its full-year adjusted sales growth forecast to about 6% from the previous 7-8%, citing consum...
Bernstein SocGen Group has reduced its price target for Applied Materials to $600, even though the company reported higher sales and profits in Q4 2026 driven by strong demand for semiconductor services, especially AI chips. Applied Materials posted ...
Boralex Inc. announced a private placement of $600 million Canadian dollars in green bonds, split into two series maturing in 2031 and 2036 with interest rates of 4.503% and 5.173%, respectively. This marks Boralex's first issuance of green corporate...
